We’ve recently updated our valuation analysis.

23andMe Holding Valuation

Is ME undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

0/6

Valuation Score 0/6

  • Price-To-Sales vs Peers

  • Price-To-Sales vs Industry

  • Price-To-Sales vs Fair Ratio

  • Below Fair Value

  • Significantly Below Fair Value

  • Analyst Forecast

Key Valuation Metric

Which metric is best to use when looking at relative valuation for ME?

Other financial metrics that can be useful for relative valuation.

ME key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue3.2x
Enterprise Value/EBITDA-3.5x
PEG Ration/a

Price to Sales Ratio vs Peers

How does ME's PS Ratio compare to its peers?

ME PS Ratio vs Peers
The above table shows the PS ratio for ME vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyPSEstimated GrowthMarket Cap
Peer Average0.7x
PIII P3 Health Partners
0.3x42.3%US$1.1b
FLGT Fulgent Genetics
1.2x-23.0%US$1.2b
MODV ModivCare
0.6x7.3%US$1.4b
MD Pediatrix Medical Group
0.7x5.6%US$1.4b
ME 23andMe Holding
4.7x6.0%US$1.3b

Price-To-Sales vs Peers: ME is expensive based on its Price-To-Sales Ratio (4.7x) compared to the peer average (0.7x).


Price to Earnings Ratio vs Industry

How does ME's PE Ratio compare vs other companies in the US Healthcare Industry?

Price-To-Sales vs Industry: ME is expensive based on its Price-To-Sales Ratio (4.7x) compared to the US Healthcare industry average (1.3x)


Price to Sales Ratio vs Fair Ratio

What is ME's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

ME PS Ratio vs Fair Ratio.
Fair Ratio
Current PS Ratio4.7x
Fair PS Ratio2x

Price-To-Sales vs Fair Ratio: ME is expensive based on its Price-To-Sales Ratio (4.7x) compared to the estimated Fair Price-To-Sales Ratio (2x).


Share Price vs Fair Value

What is the Fair Price of ME when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: Insufficient data to calculate ME's fair value for valuation analysis.

Significantly Below Fair Value: Insufficient data to calculate ME's fair value for valuation analysis.


Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Analyst Forecast: Target price is more than 20% higher than the current share price, but analysts are not within a statistically confident range of agreement.


Discover undervalued companies